Arthroscopic JointRep™ operation with microfracture
With Dr. Gennaro Pipino, Italy
View from the operation room
Dr. Gennaro Pipino (Bologna, Italy) reports reductions of WOMAC scores of over 90% in a controlled post-market study comparing microfracture + JointRepTM to microfracture alone. The study includes 69 patients from ages 18-72 suffering grade III-IV lesions, with 46 patients in the test group and 23 in the control group, both following the same moderate rehab protocol.
Arthroscopic lavage/debridement operation with JointRep™
With Dr. Nicolas Duval, Canada
Standard Arthroscopic operation (Lavage/debridement)
Preparation and injection of JointRep™ implant
The application of JointRepTM following a standard lavage/debridement operation was tested clinically in three different centers: Duval Orthopedic clinic, Canada (18 patients, mean age 50); Philippe Hardy, Hôpital Ambroise-Paré, France (19 patients, mean age 48); Military Hospital of Athens, Greece (44 patients, mean age 57).
At 6 months, patient reported outcomes showed an improvement of 50.4% of WOMAC score (Canada), 60% of WOMAC score (France), and 29.7, 32.1, 26.5 points on the KOOS pain, symptoms and daily living functions scales respectively (Greece).
JointRep applied to cartilage lesion of the patella under arthroscopic vision
JointRep™ can be premixed with platelet rich plasma (PRP) while maintaining the product's gelling property.
Video showing the mixing of B1 and B2 first, then the mixing of (B1+B2) with approximately 1 cc of PRP (or less) and finally the mixing of (B1+B2+ PRP) and A giving an injectable gel that solidifies with temperature as does JointRep™ alone.